ID   UBP10_HUMAN             Reviewed;         798 AA.
AC   Q14694; B2RDJ8; B4DS84; Q9BWG7; Q9NSL7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-MAR-2017, entry version 168.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 10;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:20096447};
DE   AltName: Full=Deubiquitinating enzyme 10;
DE   AltName: Full=Ubiquitin thioesterase 10;
DE   AltName: Full=Ubiquitin-specific-processing protease 10;
GN   Name=USP10; Synonyms=KIAA0190;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   INTERACTION WITH G3BP, AND MUTAGENESIS OF CYS-424.
RX   PubMed=11439350; DOI=10.1038/sj.onc.1204553;
RA   Soncini C., Berdo I., Draetta G.;
RT   "Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a
RT   novel human ubiquitin specific protease.";
RL   Oncogene 20:3869-3879(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V.
RT   The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-200.
RC   TISSUE=Melanoma, and Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   PRO-203 AND LEU-204.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365 AND SER-370, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH SNX3.
RX   PubMed=18632802; DOI=10.1152/ajprenal.00001.2008;
RA   Boulkroun S., Ruffieux-Daidie D., Vitagliano J.J., Poirot O.,
RA   Charles R.P., Lagnaz D., Firsov D., Kellenberger S., Staub O.;
RT   "Vasopressin-inducible ubiquitin-specific protease 10 increases ENaC
RT   cell surface expression by deubiquitylating and stabilizing sorting
RT   nexin 3.";
RL   Am. J. Physiol. 295:F889-F900(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-226 AND
RP   SER-370, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CFTR, AND MUTAGENESIS
RP   OF CYS-424.
RX   PubMed=19398555; DOI=10.1074/jbc.M109.001685;
RA   Bomberger J.M., Barnaby R.L., Stanton B.A.;
RT   "The deubiquitinating enzyme USP10 regulates the post-endocytic
RT   sorting of cystic fibrosis transmembrane conductance regulator in
RT   airway epithelial cells.";
RL   J. Biol. Chem. 284:18778-18789(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563 AND SER-576, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INDUCTION,
RP   INTERACTION WITH TP53, PHOSPHORYLATION AT THR-42 AND SER-337, AND
RP   MUTAGENESIS OF THR-42 AND SER-337.
RX   PubMed=20096447; DOI=10.1016/j.cell.2009.12.032;
RA   Yuan J., Luo K., Zhang L., Cheville J.C., Lou Z.;
RT   "USP10 regulates p53 localization and stability by deubiquitinating
RT   p53.";
RL   Cell 140:384-396(2010).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-24; SER-365; SER-370 AND SER-576, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   FUNCTION, ENZYME REGULATION, UBIQUITINATION, AND MUTAGENESIS OF
RP   CYS-424.
RX   PubMed=21962518; DOI=10.1016/j.cell.2011.08.037;
RA   Liu J., Xia H., Kim M., Xu L., Li Y., Zhang L., Cai Y., Norberg H.V.,
RA   Zhang T., Furuya T., Jin M., Zhu Z., Wang H., Yu J., Li Y., Hao Y.,
RA   Choi A., Ke H., Ma D., Yuan J.;
RT   "Beclin1 controls the levels of p53 by regulating the deubiquitination
RT   activity of USP10 and USP13.";
RL   Cell 147:223-234(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-370; SER-547 AND
RP   SER-576, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-321 AND SER-365, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   FUNCTION, IDENTIFICATION IN A DEUBIQUITINATION COMPLEX WITH TANK AND
RP   ZC3H12A, AND INTERACTION WITH IKBKG; TANK; TRAF6 AND ZC3H12A.
RX   PubMed=25861989; DOI=10.1074/jbc.M115.643767;
RA   Wang W., Huang X., Xin H.B., Fu M., Xue A., Wu Z.H.;
RT   "TRAF Family Member-associated NF-kappaB Activator (TANK) Inhibits
RT   Genotoxic Nuclear Factor kappaB Activation by Facilitating
RT   Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.";
RL   J. Biol. Chem. 290:13372-13385(2015).
CC   -!- FUNCTION: Hydrolase that can remove conjugated ubiquitin from
CC       target proteins such as p53/TP53, BECN1, SNX3 and CFTR. Acts as an
CC       essential regulator of p53/TP53 stability: in unstressed cells,
CC       specifically deubiquitinates p53/TP53 in the cytoplasm, leading to
CC       counteract MDM2 action and stabilize p53/TP53. Following DNA
CC       damage, translocates to the nucleus and deubiquitinates p53/TP53,
CC       leading to regulate the p53/TP53-dependent DNA damage response.
CC       Component of a regulatory loop that controls autophagy and
CC       p53/TP53 levels: mediates deubiquitination of BECN1, a key
CC       regulator of autophagy, leading to stabilize the PIK3C3/VPS34-
CC       containing complexes. In turn, PIK3C3/VPS34-containing complexes
CC       regulate USP10 stability, suggesting the existence of a regulatory
CC       system by which PIK3C3/VPS34-containing complexes regulate
CC       p53/TP53 protein levels via USP10 and USP13. Does not
CC       deubiquitinate MDM2. Deubiquitinates CFTR in early endosomes,
CC       enhancing its endocytic recycling. Involved in a TANK-dependent
CC       negative feedback response to attenuate NF-kappaB activation via
CC       deubiquitinating IKBKG or TRAF6 in response to interleukin-1-beta
CC       (IL1B) stimulation or upon DNA damage (PubMed:25861989).
CC       {ECO:0000269|PubMed:11439350, ECO:0000269|PubMed:18632802,
CC       ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:20096447,
CC       ECO:0000269|PubMed:21962518, ECO:0000269|PubMed:25861989}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:20096447}.
CC   -!- ENZYME REGULATION: Specifically inhibited by spautin-1 (specific
CC       and potent autophagy inhibitor-1), a derivative of MBCQ that binds
CC       to USP10 and inhibits deubiquitinase activity. Regulated by
CC       PIK3C3/VPS34-containing complexes. {ECO:0000269|PubMed:21962518}.
CC   -!- SUBUNIT: Found in a deubiquitination complex with TANK, USP10 and
CC       ZC3H12A; this complex inhibits genotoxic stress- or interleukin-1-
CC       beta (IL1B)-mediated NF-kappaB activation by promoting IKBKG or
CC       TRAF6 deubiquitination (PubMed:25861989). Interacts with IKBKG;
CC       this interaction increases in response to DNA damage
CC       (PubMed:25861989). Interacts with TANK; this interaction increases
CC       in response to DNA damage (PubMed:25861989). Interacts with TRAF6;
CC       this interaction increases in response to DNA damage
CC       (PubMed:25861989). Interacts with ZC3H12A; this interaction
CC       increases in response to DNA damage (PubMed:25861989). Interacts
CC       with G3BP, which may regulate its function (PubMed:11439350).
CC       Interacts with p53/TP53 (PubMed:20096447). Interacts with SNX3
CC       (PubMed:18632802). Interacts with CFTR (PubMed:19398555).
CC       {ECO:0000269|PubMed:11439350, ECO:0000269|PubMed:18632802,
CC       ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:20096447,
CC       ECO:0000269|PubMed:25861989}.
CC   -!- INTERACTION:
CC       Q13283:G3BP1; NbExp=4; IntAct=EBI-2510389, EBI-1047359;
CC       Q9UN86:G3BP2; NbExp=5; IntAct=EBI-2510389, EBI-1044298;
CC       Q5D1E8:ZC3H12A; NbExp=5; IntAct=EBI-2510389, EBI-747793;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20096447}.
CC       Nucleus {ECO:0000269|PubMed:20096447}. Early endosome
CC       {ECO:0000269|PubMed:19398555}. Note=Cytoplasmic in normal
CC       conditions (PubMed:20096447). After DNA damage, translocates to
CC       the nucleus following phosphorylation by ATM (PubMed:20096447).
CC       {ECO:0000269|PubMed:20096447}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14694-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14694-2; Sequence=VSP_038869;
CC       Name=3;
CC         IsoId=Q14694-3; Sequence=VSP_038868;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:11439350}.
CC   -!- INDUCTION: Following DNA damage. Down-regulated in renal cell
CC       carcinomas. {ECO:0000269|PubMed:20096447}.
CC   -!- PTM: Phosphorylated by ATM following DNA damage, leading to
CC       stablization and translocation it to the nucleus.
CC       {ECO:0000269|PubMed:20096447}.
CC   -!- PTM: Ubiquitinated. Deubiquitinated by USP13.
CC       {ECO:0000269|PubMed:21962518}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP10 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD97644.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D80012; BAA11507.1; -; mRNA.
DR   EMBL; AK299618; BAG61546.1; -; mRNA.
DR   EMBL; AK315570; BAG37945.1; -; mRNA.
DR   EMBL; AL162049; CAB82392.2; -; mRNA.
DR   EMBL; BX537402; CAD97644.1; ALT_INIT; mRNA.
DR   EMBL; AC009116; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000263; AAH00263.1; -; mRNA.
DR   CCDS; CCDS45537.1; -. [Q14694-1]
DR   CCDS; CCDS62004.1; -. [Q14694-3]
DR   RefSeq; NP_001259004.1; NM_001272075.1. [Q14694-3]
DR   RefSeq; NP_005144.2; NM_005153.2. [Q14694-1]
DR   UniGene; Hs.136778; -.
DR   ProteinModelPortal; Q14694; -.
DR   BioGrid; 114554; 63.
DR   IntAct; Q14694; 27.
DR   MINT; MINT-3030173; -.
DR   STRING; 9606.ENSP00000219473; -.
DR   BindingDB; Q14694; -.
DR   ChEMBL; CHEMBL3407323; -.
DR   MEROPS; C19.018; -.
DR   iPTMnet; Q14694; -.
DR   PhosphoSitePlus; Q14694; -.
DR   BioMuta; USP10; -.
DR   DMDM; 2501458; -.
DR   EPD; Q14694; -.
DR   MaxQB; Q14694; -.
DR   PaxDb; Q14694; -.
DR   PeptideAtlas; Q14694; -.
DR   PRIDE; Q14694; -.
DR   DNASU; 9100; -.
DR   Ensembl; ENST00000219473; ENSP00000219473; ENSG00000103194. [Q14694-1]
DR   Ensembl; ENST00000570191; ENSP00000457411; ENSG00000103194. [Q14694-3]
DR   GeneID; 9100; -.
DR   KEGG; hsa:9100; -.
DR   UCSC; uc002fii.4; human. [Q14694-1]
DR   CTD; 9100; -.
DR   DisGeNET; 9100; -.
DR   GeneCards; USP10; -.
DR   H-InvDB; HIX0173245; -.
DR   HGNC; HGNC:12608; USP10.
DR   HPA; HPA006731; -.
DR   HPA; HPA006749; -.
DR   MIM; 609818; gene.
DR   neXtProt; NX_Q14694; -.
DR   OpenTargets; ENSG00000103194; -.
DR   PharmGKB; PA37234; -.
DR   eggNOG; KOG1871; Eukaryota.
DR   eggNOG; ENOG410XSIH; LUCA.
DR   GeneTree; ENSGT00550000074994; -.
DR   HOGENOM; HOG000285959; -.
DR   HOVERGEN; HBG059823; -.
DR   InParanoid; Q14694; -.
DR   KO; K11841; -.
DR   OMA; GQEYQRI; -.
DR   OrthoDB; EOG091G023X; -.
DR   PhylomeDB; Q14694; -.
DR   TreeFam; TF323203; -.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP10; human.
DR   GeneWiki; USP10; -.
DR   GenomeRNAi; 9100; -.
DR   PRO; PR:Q14694; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103194; -.
DR   CleanEx; HS_USP10; -.
DR   ExpressionAtlas; Q14694; baseline and differential.
DR   Genevisible; Q14694; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IMP:UniProtKB.
DR   GO; GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IDA:UniProtKB.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR009818; Ataxin-2_C.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF07145; PAM2; 1.
DR   Pfam; PF00443; UCH; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Autophagy; Complete proteome;
KW   Cytoplasm; DNA damage; DNA repair; Endosome; Hydrolase; Nucleus;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   Thiol protease; Ubl conjugation; Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:20068231}.
FT   CHAIN         2    798       Ubiquitin carboxyl-terminal hydrolase 10.
FT                                /FTId=PRO_0000080629.
FT   DOMAIN      415    795       USP.
FT   REGION        2    100       Interaction with p53/TP53.
FT                                {ECO:0000269|PubMed:20096447}.
FT   ACT_SITE    424    424       Nucleophile.
FT   ACT_SITE    749    749       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      24     24       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      42     42       Phosphothreonine; by ATM.
FT                                {ECO:0000269|PubMed:20096447}.
FT   MOD_RES     100    100       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P52479}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     321    321       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     337    337       Phosphoserine; by ATM.
FT                                {ECO:0000269|PubMed:20096447}.
FT   MOD_RES     365    365       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     547    547       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     563    563       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     576    576       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17487921,
FT                                ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      6       MALHSP -> MPWLPSPGIG (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038868.
FT   VAR_SEQ       1      1       M -> MCSKDTVLSVCALYWRKGIQSHTPLIGAWRRGKQRE
FT                                QPEDRGVPMKRAA (in isoform 2).
FT                                {ECO:0000303|PubMed:8724849}.
FT                                /FTId=VSP_038869.
FT   VARIANT     200    200       M -> V (in dbSNP:rs1862792).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_015859.
FT   VARIANT     203    203       S -> P (in dbSNP:rs2326391).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_015860.
FT   VARIANT     204    204       V -> L (in dbSNP:rs1812061).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_015861.
FT   MUTAGEN      42     42       T->A: Abolishes phosphorylation by ATM;
FT                                when associated with A-337.
FT                                {ECO:0000269|PubMed:20096447}.
FT   MUTAGEN      42     42       T->E: Phospho-mimetic mutant that
FT                                translocates to the nucleus in absence of
FT                                genotoxic stress; when associated with D-
FT                                337. {ECO:0000269|PubMed:20096447}.
FT   MUTAGEN     337    337       S->A: Abolishes phosphorylation by ATM;
FT                                when associated with A-42.
FT                                {ECO:0000269|PubMed:20096447}.
FT   MUTAGEN     337    337       S->D: Phospho-mimetic mutant that
FT                                translocates to the nucleus in absence of
FT                                genotoxic stress; when associated with E-
FT                                42. {ECO:0000269|PubMed:20096447}.
FT   MUTAGEN     424    424       C->A: Abolishes de-ubiquitinating
FT                                activity. {ECO:0000269|PubMed:11439350,
FT                                ECO:0000269|PubMed:19398555,
FT                                ECO:0000269|PubMed:21962518}.
FT   CONFLICT    108    108       A -> V (in Ref. 3; BAG61546).
FT                                {ECO:0000305}.
FT   CONFLICT    263    263       T -> A (in Ref. 3; BAG61546).
FT                                {ECO:0000305}.
SQ   SEQUENCE   798 AA;  87134 MW;  E6BA77E2B5CE2B3F CRC64;
     MALHSPQYIF GDFSPDEFNQ FFVTPRSSVE LPPYSGTVLC GTQAVDKLPD GQEYQRIEFG
     VDEVIEPSDT LPRTPSYSIS STLNPQAPEF ILGCTASKIT PDGITKEASY GSIDCQYPGS
     ALALDGSSNV EAEVLENDGV SGGLGQRERK KKKKRPPGYY SYLKDGGDDS ISTEALVNGH
     ANSAVPNSVS AEDAEFMGDM PPSVTPRTCN SPQNSTDSVS DIVPDSPFPG ALGSDTRTAG
     QPEGGPGADF GQSCFPAEAG RDTLSRTAGA QPCVGTDTTE NLGVANGQIL ESSGEGTATN
     GVELHTTESI DLDPTKPESA SPPADGTGSA SGTLPVSQPK SWASLFHDSK PSSSSPVAYV
     ETKYSPPAIS PLVSEKQVEV KEGLVPVSED PVAIKIAELL ENVTLIHKPV SLQPRGLINK
     GNWCYINATL QALVACPPMY HLMKFIPLYS KVQRPCTSTP MIDSFVRLMN EFTNMPVPPK
     PRQALGDKIV RDIRPGAAFE PTYIYRLLTV NKSSLSEKGR QEDAEEYLGF ILNGLHEEML
     NLKKLLSPSN EKLTISNGPK NHSVNEEEQE EQGEGSEDEW EQVGPRNKTS VTRQADFVQT
     PITGIFGGHI RSVVYQQSSK ESATLQPFFT LQLDIQSDKI RTVQDALESL VARESVQGYT
     TKTKQEVEIS RRVTLEKLPP VLVLHLKRFV YEKTGGCQKL IKNIEYPVDL EISKELLSPG
     VKNKNFKCHR TYRLFAVVYH HGNSATGGHY TTDVFQIGLN GWLRIDDQTV KVINQYQVVK
     PTAERTAYLL YYRRVDLL
//
